Selenium Sulfide Lotion
NDC Package 45802-040-64
Package Information
Selenium Sulfide lotions is a medication used to treat dandruff and a certain scalp infection (seborrheic dermatitis). This formulation utilizes a lotion delivery system. Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-040 and is authorized under FDA application ANDA089996.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45802 - Padagis Israel Pharmaceuticals Ltd
- 45802-040 - Selenium Sulfide
- 45802-040-64 - 118 mL in 1 BOTTLE
- 45802-040 - Selenium Sulfide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45802-040-64 identifies a specific commercial package of 118 ml in 1 bottle of Selenium Sulfide, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. This lotion is formulated for topical use and contains selenium sulfide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on September 25, 2006. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat dandruff and a certain scalp infection (seborrheic dermatitis). It reduces itching, flaking, irritation, and redness of the scalp. Selenium sulfide is also used for a condition that causes discoloration of the skin (tinea versicolor). This medication belongs to a class of medications called anti-infectives. It works by slowing the growth of the yeast that causes the infection.
How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802004064. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 118 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.